New Hope for Pleural Mesothelioma: Targeting YB-1 for Enhanced Treatment
Pleural mesothelioma has been challenging to treat with limited options and a poor outlook. But, researchers have uncovered a promising…
Promising Results: Pembrolizumab Enhances Mesothelioma Treatment
Pleural mesothelioma is a challenging cancer caused by asbestos exposure. It is often diagnosed in advanced stages with limited treatment…
New Hope for Treating Pleural Mesothelioma: Breakthrough Therapies on the Horizon
Pleural mesothelioma is a rare and tough cancer with a history of limited treatment options and a difficult prognosis. But…
Expanding Treatment Horizons: CIRT’s Potential for Mesothelioma Patients
When it comes to treating early-stage cancer, surgery is often the recommended approach. But did you know that some patients…
Safety First: Managing Cisplatin Exposure After Mesothelioma Treatment
Mesothelioma is an aggressive type of cancer that affects the lining of the lungs, abdomen, or heart. It is caused…
Decoding Pleural Mesothelioma: Insights from a Ten-Year Study
Recently, a group of researchers studied 169 patients with pleural mesothelioma over ten years. They wanted to gain a deeper…
Meet FLT PET: A New Hope for Mesothelioma Patients
There’s a new tool called F18-Fluorothymidine (FLT) PET. It takes pictures inside the body and focuses on how the cancer…
Immunotherapy’s Impact on the Mesothelioma Immune System
The battle against mesothelioma has seen significant developments in recent years. Many developments are with the introduction of immunotherapy as…
Battling Mesothelioma: How PICC Devices Make a Difference in Patients’ Lives
Mesothelioma, a rare and aggressive cancer, often takes a silent toll on the lives of those affected. This disease, linked…
MTH1 Protein: A New Ally in the Fight Against Mesothelioma
Scientists are now investigating a protein known as MTH1. They are delving into its role in boosting the body’s immune…